It does seem to indicate that there are others who share my view. However, investing is in itself a risk. Investing in bio-tech is way more risky. And trading options on this sort of stock is, in my opinion, really rolling the dice. While I occasionally do trade options in this arena, I generally never make any serious money and absolutely would not presume to advise anyone else to do so. That said, the option activity does look encouraging for longs.